BeStock  
Stocks › Biotechnology › MLYS

Mineralys Therapeutics MLYS

US equityMarket cap rank #3034Biotechnology
$13.66 −$0.50 (-3.53%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $13.70 +0.29%
Open$13.81
Prev close$14.16
Day range$13.57 – $14.79
Volume1.35M
Market cap$1.21B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts6
Average target$45.50+233.1% vs. price
  • Buy 83%
  • Hold 17%
Low $19.00Now $13.66Avg $45.50High $56.00

Recent rating changes

The last 20 actions on file set price targets from $19.00 to $56.00, averaging $47.83.

DateFirmRatingTarget
10 Nov 2026 H.C. Wainwright BUY $56.00
9 Nov 2026 H.C. Wainwright BUY $56.00
6 Nov 2026 UBS HOLD $19.00
5 Nov 2026 TD Cowen BUY –
5 Nov 2026 Wells Fargo BUY $55.00
5 Nov 2026 BofA Securities BUY –
5 Nov 2026 Stifel BUY $52.00
5 Nov 2026 H.C. Wainwright BUY $56.00
23 Oct 2026 H.C. Wainwright BUY $56.00
12 Oct 2026 UBS HOLD $29.00
12 Oct 2026 BofA Securities BUY $49.00
12 Oct 2026 H.C. Wainwright BUY $56.00
11 Oct 2026 UBS HOLD $29.00
12 Aug 2026 Wells Fargo BUY $55.00
12 Aug 2026 LifeSci Capital BUY $54.00
12 Aug 2026 BofA Securities BUY $49.00
12 Aug 2026 Goldman Sachs BUY $40.00
12 Aug 2026 Guggenheim BUY $52.00
12 Aug 2026 H.C. Wainwright BUY $56.00
3 Jun 2026 Goldman Sachs BUY $42.00

Discussion

No comments yet — be the first to weigh in on MLYS.

Sign in to join the discussion.

Scroll to Top